Solifenacin

Back to search

Molecule Structure

Scientific Name

Solifenacin

Description of the Drug

Solifenacin is a muscarinic antagonist with antispasmodic properties used to treat urge urinary incontinence, urgency, and urinary frequency associated with an overactive bladder.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01591

Brand Name(s)

Vesicare

Company Owner(s)

Cipla Ltd, Alkem Laboratories Ltd, Sunshine Lake Pharma Co Ltd, Qilu Pharmaceutical Co Ltd, Watson Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Graviti Pharmaceuticals Private Ltd, Ajanta Pharma Ltd, Astellas Pharma Us Inc, Accord Healthcare Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Muscarinic acetylcholine receptor M3 SINGLE PROTEIN ANTAGONIST CHEMBL245
Muscarinic acetylcholine receptor M2 SINGLE PROTEIN ANTAGONIST CHEMBL211

Unichem Links

SureChEMBL SCHEMBL188493
DrugBank DB01591
PubChem: Thomson Pharma 16501406 16440595
PubChem 154059
LINCS LSM-45423
Nikkaji J1.594.869H
BindingDB 50344284 50370682
EPA CompTox Dashboard DTXSID3048289
DrugCentral 2457
ChemicalBook CB81179756
Guide to Pharmacology 7483
rxnorm VESICARE SOLIFENACIN SUCCINATE SOLIFENACIN
ChEBI 135530
ZINC ZINC000003936683